Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 204

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Increasing endogenous 2‐arachidonoylglycerol levels counteracts colitis and related systemic inflammation

Open access
Alhouayek, Mireille, Lambert, Didier M., Delzenne, Nathalie M., Cani, Patrice D., Muccioli, Giulio G.·2011·The FASEB Journal

Abstract

Inflammatory bowel diseases (IBDs) are chronic inflammatory conditions for which new therapeutic approaches are needed. Genetic and pharmacological data point to a protective role of CB 1 and CB 2 cannabinoid receptor activation in IBD experimental models. Therefore, increasing the endogenous levels of 2‐arachidonoylglycerol, the main full agonist of these receptors, should have beneficial effects on colitis. 2‐Arachidonoylglycerol levels were raised in the trinitrobenzene sulfonic acid (TNBS)‐induced colitis mouse model by inhibiting monoacylglycerol lipase (MAGL), the primary enzyme responsible for hydrolysis of 2‐arachidonoylglycerol, using the selective inhibitor JZL184. MAGL inhibition in diseased mice increased 2‐arachidonoylglycerol levels, leading to a reduction of macroscopic and histological colon alterations, as well as of colonic expression of proinflammatory cytokines. The restored integrity of the intestinal barrier function after MAGL inhibition resulted in reduced endotoxemia as well as reduced peripheral and brain inflammation. Coadministration of either CB 1 (SR141716A) or CB 2 (AM630) selective antagonists with JZL184 completely abolished the protective effect of MAGL inhibition on TNBS‐induced colon alterations, thus demonstrating the involvement of both cannabinoid receptors. In conclusion, increasing 2‐arachidonoylglycerol levels resulted in a dramatic reduction of colitis and of the related systemic and central inflammation. This could offer a novel pharmacological approach for the treatment of IBD based on the new protective role of 2‐arachidonoylglycerol described here.—Alhouayek, M., Lambert, D. M., Delzenne, N. M., Cani, P. D., Muccioli, G. G. Increasing endogenous 2‐arachidonoylglycerol levels counteracts colitis and related systemic inflammation. FASEB J. 25, 2711‐2721 (2011). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.10-176602

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 204

Metadata

Authors
Alhouayek, M., Lambert, D. M., Delzenne, N. M., Cani, P. D., & Muccioli, G. G.
Venue
The FASEB Journal
Publisher
Wiley
Published
2011-05-06
Volume
25
Issue
8
Pages
2711-2721
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2113045387
Cited by
204
References
5
FWCI
10.22
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increasing endogenous 2‐arachidonoylglycerol levels counteracts colitis and related systemic inflammation. https://app.cochat.ai/papers/10.1096/fj.10-176602
The paper
Alhouayek, M., Lambert, D. M., Delzenne, N. M., Cani, P. D., & Muccioli, G. G. (2011). Increasing endogenous 2‐arachidonoylglycerol levels counteracts colitis and related systemic inflammation. The FASEB Journal. https://doi.org/10.1096/fj.10-176602

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.